Dr. Reddy's Laboratories Limited (RDY)

NYSE: RDY · Real-Time Price · USD

12.25

-0.05 (-0.41%)

At close: Sep 25, 2026, 4:00 PM EDT

12.25

0.00 (0.00%)

After-hours: Sep 25, 2026, 4:15 PM EDT

Dr. Reddy's Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 25, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	10,454	11,141	11,155	12,302	9,348	9,415
Market Cap Growth	-13.66%	-0.13%	-9.32%	31.60%	-0.71%	-8.08%
Enterprise Value	10,389	11,018	11,097	11,669	8,972	9,322
Last Close Price	12.25	13.77	13.05	14.45	11.15	10.84

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 25, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	29.85	24.38	16.86	18.41	17.03	30.32
PS Ratio	2.98	3.11	2.93	3.67	3.12	3.33
PB Ratio	2.56	2.75	2.83	3.65	3.32	3.75
P/TBV Ratio	3.70	4.03	4.24	4.28	3.92	4.50
P/FCF Ratio	47.01	31.25	50.37	35.31	16.14	53.13
P/OCF Ratio	24.31	18.41	20.53	22.56	13.04	25.42

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 25, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
EV/Sales Ratio	2.97	3.08	2.91	3.48	3.00	3.30
EV/EBITDA Ratio	17.97	15.16	10.80	12.31	11.16	14.82
EV/EBIT Ratio	27.94	20.98	13.17	14.89	13.79	19.70
EV/FCF Ratio	46.72	30.91	50.10	33.49	15.50	52.61

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 25, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Debt / Equity Ratio	0.19	0.20	0.14	0.07	0.06	0.18
Debt / EBITDA Ratio	1.28	1.11	0.53	0.25	0.20	0.71
Debt / FCF Ratio	3.38	2.31	2.47	0.69	0.28	2.52
Net Debt / Equity Ratio	-0.02	-0.03	-0.03	-0.22	-0.21	-0.05
Net Debt / EBITDA Ratio	-0.17	-0.15	-0.13	-0.78	-0.73	-0.22
Net Debt / FCF Ratio	-0.44	-0.31	-0.59	-2.12	-1.02	-0.78
Asset Turnover	0.61	0.63	0.74	0.79	0.80	0.77
Inventory Turnover	2.12	2.15	2.01	2.06	2.14	2.09
Quick Ratio	1.16	1.13	1.16	1.72	1.58	1.24
Current Ratio	1.90	1.80	1.92	2.58	2.38	1.93
Return on Equity (ROE)	8.84%	11.83%	18.53%	21.77%	21.38%	12.96%
Return on Assets (ROA)	4.01%	5.74%	10.22%	11.51%	10.86%	8.04%
Return on Invested Capital (ROIC)	7.46%	10.96%	19.70%	25.19%	21.99%	15.03%
Return on Capital Employed (ROCE)	8.40%	12.00%	19.90%	22.40%	22.60%	18.10%

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 25, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Earnings Yield	3.35%	4.10%	5.93%	5.43%	5.87%	3.30%
FCF Yield	2.13%	3.20%	1.98%	2.83%	6.19%	1.88%
Dividend Yield	0.52%	0.62%	0.72%	0.66%	0.87%	0.73%
Payout Ratio	15.31%	15.54%	11.78%	11.94%	11.05%	17.59%
Buyback Yield / Dilution	0.05%	0.10%	-0.08%	-0.19%	-0.03%	-0.01%
Total Shareholder Return	0.58%	0.72%	0.64%	0.47%	0.84%	0.71%

SEC Filings: 10-K · 10-Q